Trial NCT01925612

View at ClinicalTrials.gov 
Org. Study IDs: SGN35-017

Last trial update was posted on 2018-06-21

MeSH Interventions

Antibodies, Monoclonal Brentuximab Vedotin Cyclophosphamide Doxorubicin Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Lymphoma, B-cell Lymphoma, Large B-cell, Diffuse

Stopping Reasons

Sponsor decision based on portfolio prioritization and changing treatment landscape in frontline DLBCL

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID